Multiple Myeloma

Showing NaN - NaN of 258

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, High Risk Smoldering Multiple Myeloma Trial in United States (Ixazomib (MLN9708), Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • High Risk Smoldering Multiple Myeloma
  • Basking Ridge, New Jersey
  • +5 more
Nov 15, 2022

Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

Completed
  • Multiple Myeloma
  • +3 more
  • Denver, Colorado
  • +4 more
Nov 14, 2022

Multiple Myeloma Trial in Leicester (CC-92480, Tazemetostat, BMS-986158)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +9 more
Oct 24, 2022

Multiple Myeloma Trial in Australia, United States (AMG 224)

Completed
  • Multiple Myeloma
  • AMG 224
  • West Hollywood, California
  • +4 more
Oct 12, 2022

Multiple Myeloma Trial in United States (CC-95266, Fludarabine, Cyclophosphamide)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +19 more
Oct 11, 2022

Multiple Myeloma Trial in New York (Tremelimumab, Durvalumab, Prevnar-13)

Terminated
  • Multiple Myeloma
  • New York, New York
  • +1 more
Oct 3, 2022

Multiple Myeloma Trial in United States (Belantamab Mafodotin, Nirogacestat)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Oct 5, 2022

Multiple Myeloma Trial in Japan, United States (JNJ-68284528)

Completed
  • Multiple Myeloma
  • JNJ-68284528
  • Phoenix, Arizona
  • +20 more
Oct 5, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

Active, not recruiting
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Beverly Hills, California
  • +75 more
Oct 4, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +139 more
Sep 9, 2022

Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
  • Atlanta, Georgia
  • +25 more
Aug 31, 2022

Multiple Myeloma Trial in United States (SEA-BCMA, dexamethasone, pomalidomide)

Recruiting
  • Multiple Myeloma
  • Palo Alto, California
  • +10 more
Aug 24, 2022

Multiple Myeloma Trial in Germany, United States (TNB-383B)

Recruiting
  • Multiple Myeloma
  • San Francisco, California
  • +14 more
Aug 22, 2022

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Orlando, Florida
  • +240 more
Aug 18, 2022

Multiple Myeloma Trial in Worldwide (REGN5458)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +26 more
Aug 16, 2022

Multiple Myeloma Trial in Worldwide (Cilta-cel)

Recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +30 more
Aug 11, 2022

Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +11 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC

Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022

Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab, Questionnaires)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022

Multiple Myeloma Trial in United States (procedure, drug, biological)

Completed
  • Multiple Myeloma
  • Tumor Cell Collection
  • +6 more
  • San Francisco, California
  • +14 more
Jul 11, 2022

Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))

Recruiting
  • Multiple Myeloma
  • Cilta-cel
  • Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
  • Duarte, California
  • +23 more
Aug 1, 2022

Multiple Myeloma Trial in United States (Carfilzomib, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Atlanta, Georgia
  • +8 more
Jul 28, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma With Failed Remission Trial in United States (FOR46)

Completed
  • Multiple Myeloma
  • +2 more
  • San Francisco, California
  • +6 more
Jul 25, 2022